Massachusetts Financial Services’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-63,057
| Closed | -$591K | – | 871 |
|
|
2023
Q3 | $591K | Sell |
63,057
-2,417
| -4% | -$22.6K | ﹤0.01% | 794 |
|
|
2023
Q2 | $1.61M | Sell |
65,474
-1,542
| -2% | -$37.8K | ﹤0.01% | 721 |
|
|
2023
Q1 | $1.56M | Sell |
67,016
-39,948
| -37% | -$930K | ﹤0.01% | 723 |
|
|
2022
Q4 | $2.71M | Buy |
106,964
+2,257
| +2% | +$57.1K | ﹤0.01% | 699 |
|
|
2022
Q3 | $2.02M | Sell |
104,707
-958
| -0.9% | -$18.5K | ﹤0.01% | 724 |
|
|
2022
Q2 | $2.69M | Buy |
105,665
+537
| +0.5% | +$13.7K | ﹤0.01% | 691 |
|
|
2022
Q1 | $2.7M | Buy |
+105,128
| New | +$2.7M | ﹤0.01% | 721 |
|
|
2021
Q2 | – | Sell |
-20,152
| Closed | -$1.03M | – | 942 |
|
|
2021
Q1 | $1.03M | Sell |
20,152
-33,335
| -62% | -$1.71M | ﹤0.01% | 832 |
|
|
2020
Q4 | $1.43M | Buy |
53,487
+17,741
| +50% | +$475K | ﹤0.01% | 770 |
|
|
2020
Q3 | $1.23M | Buy |
+35,746
| New | +$1.23M | ﹤0.01% | 760 |
|